Josep Tabernero has been named as Cancer Core Europe’s New Chairman of the Board of Directors

Cancer Core Europe (CCE), an association of seven premier cancer centres in Europe, is happy to announce a change to its Board of Directors. After a successful period, Emile Voest from the Netherlands Cancer Institute (NKI) passed the position of chairman to Josep Tabernero from the Vall d’Hebron Institute of Oncology (VHIO).

Dr. Tabernero is Head of the Department of Medical Oncology at Vall d’Hebron University Hospital, Director of the Vall d’Hebron Institute of Oncology (VHIO), and Professor of Medicine at UVic-UCC. He has been the principal investigator of several phase I pharmacodynamic studies and translational projects with tumor-targeted therapies and immune-based therapies. Dr. Tabernero is on the editorial boards of various leading journals, such as Annals of Oncology, ESMO Open, and Cancer Discovery, among others. He has been part of the CCE Board of Directors since 2014, was president (2018–2019) of the European Society for Medical Oncology (ESMO), and is also part of the Public Policy and Antineoplastic Drugs commissions.

In comments about his new position as board chairman, Josep Tabernero stated his eagerness to take on the challenge: “I really appreciate the opportunity; I am grateful for the trust and thrilled for the challenge. I will continue Emile’s strategy to improve cancer care and cancer research in Europe”.  

We are convinced that his leadership will provide CCE with a new and insightful viewpoint, advancing our efforts to more quickly move cancer research into the clinic for the benefit of patients. 

On the other hand, we would like to thank Emile Voest for his admirable leadership after serving Cancer Core Europe with distinction over the past four years. His unwavering dedication and strategic vision have been crucial to CCE’s expansion and ongoing success. We genuinely appreciate his commitment and significant effort.

To learn more about Cancer Core Europe, please visit